BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34915416)

  • 21. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in aptamer-mediated targeted delivery system for cancer treatment.
    He S; Du Y; Tao H; Duan H
    Int J Biol Macromol; 2023 May; 238():124173. PubMed ID: 36965552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors.
    Cibiel A; Quang NN; Gombert K; Thézé B; Garofalakis A; Ducongé F
    PLoS One; 2014; 9(1):e87002. PubMed ID: 24489826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro selection of DNA aptamers for metastatic breast cancer cell recognition and tissue imaging.
    Li X; Zhang W; Liu L; Zhu Z; Ouyang G; An Y; Zhao C; Yang CJ
    Anal Chem; 2014 Jul; 86(13):6596-603. PubMed ID: 24892693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro selection of aptamer S1 against MCF-7 human breast cancer cells.
    Zhang WY; Chen HL; Chen QC
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2393-2397. PubMed ID: 31196711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection and Identification of Novel Aptamers Specific for Clenbuterol Based on ssDNA Library Immobilized SELEX and Gold Nanoparticles Biosensor.
    Liu X; Lu Q; Chen S; Wang F; Hou J; Xu Z; Meng C; Hu T; Hou Y
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30216975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
    Delač M; Motaln H; Ulrich H; Lah TT
    Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applications of Aptamer-Bound Nanomaterials in Cancer Therapy.
    Zhu L; Zhao J; Guo Z; Liu Y; Chen H; Chen Z; He N
    Biosensors (Basel); 2021 Sep; 11(9):. PubMed ID: 34562934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
    Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
    J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle-aptamer conjugates for cancer cell targeting and detection.
    Estévez MC; Huang YF; Kang H; O'Donoghue MB; Bamrungsap S; Yan J; Chen X; Tan W
    Methods Mol Biol; 2010; 624():235-48. PubMed ID: 20217600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aptamers in targeted nanotherapy.
    Mathew A; Maekawa T; Sakthikumar D
    Curr Top Med Chem; 2015; 15(12):1102-14. PubMed ID: 25866269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
    Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach.
    Fang X; Tan W
    Acc Chem Res; 2010 Jan; 43(1):48-57. PubMed ID: 19751057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aptamers: molecular tools for medical diagnosis.
    Ozalp VC; Kavruk M; Dilek O; Bayrac AT
    Curr Top Med Chem; 2015; 15(12):1125-37. PubMed ID: 25866272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aptamer-Modified Nanoparticles in Medical Applications.
    Eilers A; Witt S; Walter J
    Adv Biochem Eng Biotechnol; 2020; 174():161-193. PubMed ID: 32157319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is less more? Lessons from aptamer selection strategies.
    Szeitner Z; András J; Gyurcsányi RE; Mészáros T
    J Pharm Biomed Anal; 2014 Dec; 101():58-65. PubMed ID: 24877649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycan-Imprinted Magnetic Nanoparticle-Based SELEX for Efficient Screening of Glycoprotein-Binding Aptamers.
    Ma Y; Li X; Li W; Liu Z
    ACS Appl Mater Interfaces; 2018 Nov; 10(47):40918-40926. PubMed ID: 30379519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aptamers: new arrows to target dendritic cells.
    Ganji A; Varasteh A; Sankian M
    J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly stable aptamers selected from a 2'-fully modified fGmH RNA library for targeting biomaterials.
    Friedman AD; Kim D; Liu R
    Biomaterials; 2015 Jan; 36():110-23. PubMed ID: 25443790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.